TY - JOUR
T1 - American society of clinical oncology statement
T2 - Human papillomavirus vaccination for cancer prevention
AU - Bailey, Howard H.
AU - Chuang, Linus T.
AU - DuPont, Nefertiti C.
AU - Eng, Cathy
AU - Foxhall, Lewis E.
AU - Merrill, Janette K.
AU - Wollins, Dana S.
AU - Blanke, Charles D.
N1 - Publisher Copyright:
© 2016 by American Society of Clinical Oncology.
PY - 2016/5/20
Y1 - 2016/5/20
N2 - American Society of Clinical Oncology (ASCO), the leading medical professional oncology society, is committed to lessening the burden of cancer and as such will promote underused interventions that have the potential to savemillions of lives through cancer prevention. As themain providers of cancer care worldwide, our patients, their families, and our communities look to us for guidance regarding all things cancer related, including cancer prevention. Through this statement and accompanying recommendations, ASCO hopes to increase awareness of the tremendous global impact of human papillomavirus (HPV) -caused cancers, refocus the discussion of HPV vaccination on its likely ability to prevent millions of cancer deaths, and increase HPV vaccination uptake via greater involvement of oncology professionals in ensuring accurate public discourse about HPV vaccination and calling for the implementation of concrete strategies to address barriers to vaccine access and acceptance.
AB - American Society of Clinical Oncology (ASCO), the leading medical professional oncology society, is committed to lessening the burden of cancer and as such will promote underused interventions that have the potential to savemillions of lives through cancer prevention. As themain providers of cancer care worldwide, our patients, their families, and our communities look to us for guidance regarding all things cancer related, including cancer prevention. Through this statement and accompanying recommendations, ASCO hopes to increase awareness of the tremendous global impact of human papillomavirus (HPV) -caused cancers, refocus the discussion of HPV vaccination on its likely ability to prevent millions of cancer deaths, and increase HPV vaccination uptake via greater involvement of oncology professionals in ensuring accurate public discourse about HPV vaccination and calling for the implementation of concrete strategies to address barriers to vaccine access and acceptance.
UR - http://www.scopus.com/inward/record.url?scp=84969504946&partnerID=8YFLogxK
U2 - 10.1200/JCO.2016.67.2014
DO - 10.1200/JCO.2016.67.2014
M3 - Article
C2 - 27069078
AN - SCOPUS:84969504946
SN - 0732-183X
VL - 34
SP - 1803
EP - 1812
JO - Journal of Clinical Oncology
JF - Journal of Clinical Oncology
IS - 15
ER -